📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. (2017)

First Author: Snowdon VK

Attributed to: Transforming Translational Research at the University of Bristol funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002248

PubMed Identifier: 28245243

Publication URI: http://europepmc.org/abstract/MED/28245243

Type: Journal Article/Review

Volume: 14

Parent Publication: PLoS medicine

Issue: 2

ISSN: 1549-1277